Copyright Reports & Markets. All rights reserved.

Global Post herpetic Neuralgia Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Post herpetic Neuralgia Treatment by Type
    • 1.3.1 Overview: Global Post herpetic Neuralgia Treatment Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Post herpetic Neuralgia Treatment Consumption Value Market Share by Type in 2025
    • 1.3.3 Anticonvulsants
    • 1.3.4 Skin Patch
    • 1.3.5 Other
  • 1.4 Global Post herpetic Neuralgia Treatment Market by Distribution Channel
    • 1.4.1 Overview: Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Online Pharmacies
    • 1.4.4 Retail Pharmacies
  • 1.5 Global Post herpetic Neuralgia Treatment Market Size & Forecast
  • 1.6 Global Post herpetic Neuralgia Treatment Market Size and Forecast by Region
    • 1.6.1 Global Post herpetic Neuralgia Treatment Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Post herpetic Neuralgia Treatment Market Size by Region, (2021-2032)
    • 1.6.3 North America Post herpetic Neuralgia Treatment Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Post herpetic Neuralgia Treatment Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Post herpetic Neuralgia Treatment Market Size and Prospect (2021-2032)
    • 1.6.6 South America Post herpetic Neuralgia Treatment Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Post herpetic Neuralgia Treatment Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Post herpetic Neuralgia Treatment Product and Solutions
    • 2.1.4 Pfizer Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Arbor Pharma
    • 2.2.1 Arbor Pharma Details
    • 2.2.2 Arbor Pharma Major Business
    • 2.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Product and Solutions
    • 2.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Arbor Pharma Recent Developments and Future Plans
  • 2.3 Assertio Therapeutics
    • 2.3.1 Assertio Therapeutics Details
    • 2.3.2 Assertio Therapeutics Major Business
    • 2.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Product and Solutions
    • 2.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Assertio Therapeutics Recent Developments and Future Plans
  • 2.4 Endo Pharma
    • 2.4.1 Endo Pharma Details
    • 2.4.2 Endo Pharma Major Business
    • 2.4.3 Endo Pharma Post herpetic Neuralgia Treatment Product and Solutions
    • 2.4.4 Endo Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Endo Pharma Recent Developments and Future Plans
  • 2.5 Teikoku Pharma
    • 2.5.1 Teikoku Pharma Details
    • 2.5.2 Teikoku Pharma Major Business
    • 2.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Product and Solutions
    • 2.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Teikoku Pharma Recent Developments and Future Plans
  • 2.6 Teva
    • 2.6.1 Teva Details
    • 2.6.2 Teva Major Business
    • 2.6.3 Teva Post herpetic Neuralgia Treatment Product and Solutions
    • 2.6.4 Teva Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Teva Recent Developments and Future Plans
  • 2.7 Mylan
    • 2.7.1 Mylan Details
    • 2.7.2 Mylan Major Business
    • 2.7.3 Mylan Post herpetic Neuralgia Treatment Product and Solutions
    • 2.7.4 Mylan Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Mylan Recent Developments and Future Plans
  • 2.8 Hengrui Medicine
    • 2.8.1 Hengrui Medicine Details
    • 2.8.2 Hengrui Medicine Major Business
    • 2.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Product and Solutions
    • 2.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Hengrui Medicine Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Post herpetic Neuralgia Treatment Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Post herpetic Neuralgia Treatment by Company Revenue
    • 3.2.2 Top 3 Post herpetic Neuralgia Treatment Players Market Share in 2025
    • 3.2.3 Top 6 Post herpetic Neuralgia Treatment Players Market Share in 2025
  • 3.3 Post herpetic Neuralgia Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Post herpetic Neuralgia Treatment Market: Region Footprint
    • 3.3.2 Post herpetic Neuralgia Treatment Market: Company Product Type Footprint
    • 3.3.3 Post herpetic Neuralgia Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Post herpetic Neuralgia Treatment Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Post herpetic Neuralgia Treatment Market Forecast by Type (2027-2032)

5 Market Size Segment by Distribution Channel

  • 5.1 Global Post herpetic Neuralgia Treatment Consumption Value Market Share by Distribution Channel (2021-2026)
  • 5.2 Global Post herpetic Neuralgia Treatment Market Forecast by Distribution Channel (2027-2032)

6 North America

  • 6.1 North America Post herpetic Neuralgia Treatment Consumption Value by Type (2021-2032)
  • 6.2 North America Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2021-2032)
  • 6.3 North America Post herpetic Neuralgia Treatment Market Size by Country
    • 6.3.1 North America Post herpetic Neuralgia Treatment Consumption Value by Country (2021-2032)
    • 6.3.2 United States Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Post herpetic Neuralgia Treatment Consumption Value by Type (2021-2032)
  • 7.2 Europe Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2021-2032)
  • 7.3 Europe Post herpetic Neuralgia Treatment Market Size by Country
    • 7.3.1 Europe Post herpetic Neuralgia Treatment Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 7.3.3 France Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2021-2032)
  • 8.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Post herpetic Neuralgia Treatment Consumption Value by Region (2021-2032)
    • 8.3.2 China Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 8.3.5 India Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Post herpetic Neuralgia Treatment Consumption Value by Type (2021-2032)
  • 9.2 South America Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2021-2032)
  • 9.3 South America Post herpetic Neuralgia Treatment Market Size by Country
    • 9.3.1 South America Post herpetic Neuralgia Treatment Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Distribution Channel (2021-2032)
  • 10.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Post herpetic Neuralgia Treatment Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Post herpetic Neuralgia Treatment Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Post herpetic Neuralgia Treatment Market Drivers
  • 11.2 Post herpetic Neuralgia Treatment Market Restraints
  • 11.3 Post herpetic Neuralgia Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Post herpetic Neuralgia Treatment Industry Chain
  • 12.2 Post herpetic Neuralgia Treatment Upstream Analysis
  • 12.3 Post herpetic Neuralgia Treatment Midstream Analysis
  • 12.4 Post herpetic Neuralgia Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Post herpetic Neuralgia Treatment market size was valued at US$ 1828 million in 2025 and is forecast to a readjusted size of US$ 2383 million by 2032 with a CAGR of 3.9% during review period.
    Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
    Global Post herpetic Neuralgia Treatment key players include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, etc. Global top five manufacturers hold a share about 80%.
    North America is the largest market, with a share over 50%, followed by Europe and China, both have a share about 30 percent.
    In terms of product, Anticonvulsants is the largest segment, with a share over 80%. And in terms of distribution channel, the largest distribution channel is Hospital Pharmacies, followed by Retail Pharmacies.
    This report is a detailed and comprehensive analysis for global Post herpetic Neuralgia Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Distribution Channel. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Post herpetic Neuralgia Treatment market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Post herpetic Neuralgia Treatment market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Post herpetic Neuralgia Treatment market size and forecasts, by Type and by Distribution Channel, in consumption value ($ Million), 2021-2032
    Global Post herpetic Neuralgia Treatment market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Post herpetic Neuralgia Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Post herpetic Neuralgia Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Arbor Pharma, Assertio Therapeutics, Endo Pharma, Teikoku Pharma, Teva, Mylan, Hengrui Medicine, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Post herpetic Neuralgia Treatment market is split by Type and by Distribution Channel. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Distribution Channel. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Anticonvulsants
    Skin Patch
    Other
    Market segment by Distribution Channel
    Hospital Pharmacies
    Online Pharmacies
    Retail Pharmacies
    Market segment by players, this report covers
    Pfizer
    Arbor Pharma
    Assertio Therapeutics
    Endo Pharma
    Teikoku Pharma
    Teva
    Mylan
    Hengrui Medicine
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Post herpetic Neuralgia Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Post herpetic Neuralgia Treatment, with revenue, gross margin, and global market share of Post herpetic Neuralgia Treatment from 2021 to 2026.
    Chapter 3, the Post herpetic Neuralgia Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Distribution Channel, with consumption value and growth rate by Type, by Distribution Channel, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Post herpetic Neuralgia Treatment market forecast, by regions, by Type and by Distribution Channel, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Post herpetic Neuralgia Treatment.
    Chapter 13, to describe Post herpetic Neuralgia Treatment research findings and conclusion.

    Buy now